Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Non-Current Deffered Revenue (2016 - 2025)

Sensus Healthcare (SRTS) has 10 years of Non-Current Deffered Revenue data on record, last reported at $21000.0 in Q3 2025.

  • For Q3 2025, Non-Current Deffered Revenue fell 68.18% year-over-year to $21000.0; the TTM value through Sep 2025 reached $21000.0, down 68.18%, while the annual FY2024 figure was $55000.0, 8.33% down from the prior year.
  • Non-Current Deffered Revenue reached $21000.0 in Q3 2025 per SRTS's latest filing, down from $32000.0 in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $418000.0 in Q1 2021 and bottomed at $21000.0 in Q3 2025.
  • Average Non-Current Deffered Revenue over 5 years is $142578.9, with a median of $116000.0 recorded in 2023.
  • Peak YoY movement for Non-Current Deffered Revenue: plummeted 68.25% in 2024, then grew 7.5% in 2025.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $262000.0 in 2021, then crashed by 46.95% to $139000.0 in 2022, then plummeted by 56.83% to $60000.0 in 2023, then dropped by 8.33% to $55000.0 in 2024, then tumbled by 61.82% to $21000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Deffered Revenue were $21000.0 in Q3 2025, $32000.0 in Q2 2025, and $43000.0 in Q1 2025.